GL1X · GenesisL1 explorer

MolNFT v1 · #134398 · protein

Crystal structure of C. jejuni pgld in complex with 5-methyl-4- (methylamino)-2-PHENETHYLTHIENO[2,3-D]PYRIMIDINE-6-carboxylic acid

5T2Y · Udp-N-acetylbacillosamine N-acetyltransferase: “Crystal structure of C. jejuni pgld in complex with 5-methyl-4…”. X-ray diffraction, 1 ligand (753), 1 pocket (best druggability 0.50). MolNFT v1 #134398 on GenesisL1: 3D structure…

PDB
5T2Y
Type
protein
Length
384 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Udp-N-acetylbacillosamine N-acetyltransferase
EC
2.3.1.203
UniProt
Q0P9D1
Ligands
753
Pockets
1 · best druggability 0.50

Structure

x-ray diffraction · 1 distinct chain · 14% helix, 29% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BUdp-N-acetylbacillosamine N-acetyltransferase (EC 2.3.1.203)protein19214% helix, 29% strandQ0P9D1

Ligands and binding sites

  • 753 · 5-methyl-4-(methylamino)-2-(2-phenylethyl)thieno[2,3-d]pyrimidine-6-carboxylic acid · ligand · 2 copies · chains A, B
  • GOL · Glycerol · additive · 3 copies · chains A, B
  • DMS · Dimethyl sulfoxide · additive · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12170.500.7534empty

Interfaces

1 interface between chains.

  • A–B · 480 Ų buried · 1 hydrogen bond · protein-protein

Compared structures

  • 5T2Y · Crystal Structure of C. jejuni PglD in complex with… · the same entry in another collection · chain A against A, TM-score 1.00
  • Q0P9D1 · AlphaFold monomer V2.0 prediction for udp-N-acetylbacillosamine N-acetyltransferase… · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.